Most weight-management, hormone, and longevity programs are better with labs — and most lose a meaningful share of patients at exactly the moment they are asked to go somewhere else to get stuck. Drawing on site removes that drop-off. It also introduces requirements that a vendor signup does not cover.
Why send-outs leak patients
You evaluate a patient, they are motivated, and then you hand them a requisition and an address. Now the program depends on them booking a second appointment, travelling, and following through — often before they have received any benefit.
A share simply never go. They are not refusing treatment; they are hitting friction at the least committed point in the relationship. Every step between decision and draw costs you conversions and delays the start of therapy.
What in-house draws actually require
| Component | What it means |
|---|---|
| Ordering provider | Labs are ordered by a licensed provider — the order is a clinical act |
| Someone qualified to draw | Phlebotomy performed by appropriately licensed or trained staff; scope varies by state |
| Reference lab relationship | An account with the lab performing the analysis, with your ordering providers set up |
| Supplies and kits | Tubes, needles, sharps disposal, centrifuge where required |
| Specimen handling | Correct tubes, correct order of draw, spin and storage requirements |
| Courier or logistics | Scheduled pickup that matches specimen stability windows |
| Results routing | Results returning into the clinical record where a provider reviews and acts |
| Abnormal result protocol | What happens on a critical value, and who is reachable |
| CLIA posture | Any testing you perform on site — even waived tests — carries its own requirements |
The last two are where operations that “have labs” often turn out not to. Results arriving in an inbox nobody owns is not a lab program.
The part that matters clinically
Labs are only useful if someone acts on them. That means a provider reviews every result, documents the interpretation, and adjusts or stops therapy accordingly — including the uncomfortable cases where the result means the patient should not continue.
A program that draws baseline labs and never revisits them is generating cost and liability without generating clinical value. If you are going to draw, close the loop.
What it changes commercially
- Conversion. The step that lost patients disappears.
- Speed to therapy. Days instead of weeks between decision and start.
- Retention. Follow-up panels create a clinical reason to return that is not a discount.
- Credibility. Monitoring is what separates a medical program from a supplement sale.
- Clinical defensibility. Documented baselines and follow-up support the decisions you made.
Common mistakes
- Drawing without an order. The draw follows a provider’s order; it does not replace one.
- Panels chosen by price rather than relevance. A cheap broad panel produces incidental findings someone then has to manage.
- No abnormal-result path. Nobody has decided who calls the patient about a critical value.
- Specimen handling shortcuts. Wrong tube, missed spin, or a delayed courier ruins the sample and the patient’s trust.
- Results in a silo. Living in the lab portal instead of the chart the provider actually uses.
- Ignoring CLIA for on-site testing. Even waived testing carries obligations.
How MDside sets this up
MDside integrates lab draws into the location you already operate. We supply the ordering providers, establish the reference lab relationship and requisitions, set up specimen handling and courier logistics, and route results back into the clinical record where a provider reviews them — with protocols defining what happens on an abnormal or critical value.
That sits on top of the same clinical structure that handles evaluation and prescribing, so a lab result actually changes what the patient is prescribed. See what is included, or read about pharmacy sourcing relationships.
Frequently asked questions
Can I draw blood at my med spa or gym?
With the right pieces in place — a provider ordering the labs, appropriately qualified staff drawing, a reference lab relationship, and correct specimen handling. Scope-of-practice rules for who may draw vary by state.
Do I need a CLIA certificate?
If you perform any testing on site, including waived tests, CLIA requirements apply. If you only collect specimens and send them to a reference lab, the analysis happens under the lab’s certification — confirm your specific setup.
Who reviews the results?
A licensed provider, who documents the interpretation and acts on it. Results that nobody reviews are a liability rather than an asset.
Can patients use their insurance for labs?
It depends on the lab, the panel, and your billing posture — and billing third-party payors can change your licensure obligations in some states. Many cash-pay programs deliberately stay cash-pay for that reason.
What happens with an abnormal result?
Your protocol should define it in advance: who is notified, how fast, who contacts the patient, and when therapy is paused or stopped.
General information about integrating lab services, not legal advice. Scope-of-practice, CLIA, and licensure requirements vary by state. Confirm with healthcare counsel and your reference laboratory.